2023 AGM and Scientific Conference
Archived event — 2023. Registration and abstract submissions for this meeting are closed. Contact the Society for conference information.
-
-
2022 AGM and Scientific Conference
Our 31st Annual AGM is fast approaching. The theme for this year’s AGM is: Promoting Good Vision and Eye Health in Children through Optimal Care and Management Date: Thursday 15th September to Sunday 18th September, 2022. Location: Peninsula Resort, Akosombo
-
Cardiovascular disease implicated in rapid glaucoma progression
To further understand the systemic and ocular risk factors for rapid glaucoma progression, investigators examined a cohort of rapid and nonrapid disease progressors. Study design Investigators compared medical histories and clinical features of 54 rapidly progressing glaucoma eyes (≥1dB mean deviation (MD)/year) with 486 non-rapidly progressing eyes(<1 dB MD/yr). All patients underwent at least 5…
-
Meta-analysis finds comparable safety profiles between bevacizumab and ranibizumab
Using data from 5 multicenter randomized trials, investigators compared the risk of systemic adverse events (SAE) associated with ranibizumab and bevacizumab for treatment of neovascular AMD. Study design While previous meta-analyses have assessed risk using aggregate data, this study used individual patient data adjusted for baseline factors such as smoking status and diabetes. The…
-
Low-cost ziv-aflibercept appears safe for intraocular administration
A multicenter study adds evidence that intravitreal ziv-aflibercept, a low-cost formulation of aflibercept originally developed as a systemic chemotherapy agent, is safe for treatment of retinal diseases. Study design Investigators from 3 centers enrolled 60 consecutive patients (65 eyes) with neovascular AMD, DME, CME associated with CRVO, or pseudophakic CME. Subjects received 6 or more…
-
Telemedicine screening confirms acute ROP is typically symmetrical
In this secondary analysis of the Telemedicine Approaches to Evaluating Acute-phase ROP (e-ROP) study, investigators examined the intereye agreement of ROP features and severity using trained nonphysician graders. Study design The NIH-funded e-ROP study evaluated the feasibility of telemedicine to identify infants with referral-warranted ROP, defined as the presence of stage 3 or above, plus…
-
Timing of IOL repositioning surgery significantly impacts refractive outcomes
This large retrospective study analyzed the incidence and appropriate timing of repositioning surgery to correct misalignment of toric IOLs. Study design The retrospective, multicenter case series included 6,431 eyes who received acrylic foldable toric IOLs after phacoemulsification. Outcomes included rate and timing of IOL repositioning, as well as residual IOL misalignment, refractive outcome and need…
-
Injected mitomycin C offers advantages over standard application
This multicenter, randomized clinical trial compared 2 methods for applying mitomycin C (MMC) in eyes undergoing trabeculectomy. Study design Investigators enrolled 80 consecutive patients undergoing trabeculectomies. Patients received either conventional intraoperative application of MMC-soaked sponges (0.02%) or a preoperative injection of MMC into the subtenon space (0.01 ml of 0.01%). Patients were evaluated at months…
-
Panel issues first U.S. guidelines for childhood retinoblastoma screening
An expert panel of ocular oncologists, pathologists and geneticists has established guidelines that could facilitate care and eliminate unnecessary exams for children at risk of retinoblastoma (Rb). Study design The recommendations were developed over a 2-year period by physicians from Rb referral centers in the U.S. and Canada. Led by members of the American Association of…
